News Articles Tagged: Ranitidine Impurity

Understanding Ranitidine Impurities: The Role of 1,1-Bis(methylthio)-2-nitroethene

Learn about Ranitidine impurities, focusing on 1,1-Bis(methylthio)-2-nitroethene (CAS 13623-94-4). Discover its importance for quality control and analytical standards in the pharmaceutical industry.

Sourcing 1,1-Bis(methylthio)-2-nitroethene: A Guide for Pharmaceutical Buyers

Looking to buy 1,1-Bis(methylthio)-2-nitroethene (CAS 13623-94-4)? This guide covers key considerations for pharmaceutical buyers, focusing on purity, supply, and pricing from reputable manufacturers.

Navigating the Market: Sourcing Ranitidine Powder Amidst Regulatory Scrutiny

Examine the current market status of Ranitidine powder, discussing the impact of NDMA concerns and the importance of due diligence when sourcing this pharmaceutical ingredient.

Ranitidine Powder: Addressing the Concerns of NDMA Impurities

An overview of the NDMA impurity concerns related to Ranitidine Powder, discussing regulatory responses and the importance of supply chain transparency.